2256 GMT - Ansell's healthcare margins are seen at Jefferies as the driver of the Australia-listed company's earnings beat. Analyst Vanessa Thomson, who has a last-published buy rating on the stock, tells clients in a note that the personal-protective equipment maker benefited from sales of its higher-margin cleanroom gloves. She adds that the bottom end of Ansell's FY27 earnings-per-share guidance range is higher than both her forecast and consensus hopes. Jefferies has a last-published target price of A$38.20. Shares are at A$34.90 ahead of the open.